ask="14.81"
ask_size="100"
average_daily_volume="78624"
bid="8.00"
bid_size="200"
book_value="-48.49"
change="-0.08"
change_from_200_day_moving_average="-0.93"
change_from_50_day_moving_average="0.40"
change_from_52_week_high="-5.84"
change_From_52_week_low="1.77"
change_in_percent="-0.79%"
close="10.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-26.44"
ebitda="-16.46M"
eps_estimate_current_year="-4.66"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-1.80"
ex_dividend_date="N/A"
float_shares="7492000"
high="10.28"
high_52_weeks="15.88"
last_trade_date="2/1/2017"
last_trade_price="10.04"
last_trade_size="598"
last_trade_time="4:00pm"
low="9.92"
low_52_weeks="8.27"
market_capitalization="168.39M"
moving_average_200_day="10.97"
moving_average_50_day="9.64"
name="Obalon Therapeutics
Inc."
notes="N/A"
one_year_target_price="19.00"
open="10.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.52%"
percent_change_from_50_day_moving_average="+4.16%"
percent_change_from_52_week_high="-36.78%"
percent_change_from_52_week_low="+21.40%"
previous_close="10.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="47.10"
revenue="3.60M"
shares_outstanding="16772000"
short_ratio="4.43"
stock_exchange="NGM"
symbol="OBLN"
volume="34523"
weeks_range_52="8.27 - 15.88"
